Comparing GH Secretagogues to GLP-1 Agonists Both GH secretagogues and GLP-1 agonists influence body composition, but through fundamentally different mechanisms
We're giving you 90 days' notice to figure out what you want to do.'" From 2025 to 2026, 12 million people were on plans that dropped coverage for Zepbound and 12 million had plans that dropped Wegovy, another GLP-1, according to research by GoodRx, a website that helps patients find discounts on prescription drugs
In 2007, the BFP tested a prototype for amphibious retrofits of shotgun-style houses in New Orleans (see drawing, p
Listen to more of the conversation with Barb Stuckey on IFTs Omnivore podcast and read about the impact of anti-obesity drugs in the March issue of Food Technology magazine
Gut 66:630
Traditionally, patients seeking a GLP-1 undergo a evaluation by a physician to determine whether they meet medical criteria typically a body mass index of 30 or higher, or certain obesity-related conditions and after discussing nutrition, exercise, potential side effects, and the likelihood that treatment may need to be lifelong